FIPB clears GlaxoSmithKline's Rs 6,400-crore FDI proposal

FIPB on Monday cleared Rs 6,400-crore (Rs 64-billion) foreign direct investment proposal of GlaxoSmithKline to acquire additional 24.33 per cent stake in its India arm. "The proposal of......

Govt clears GlaxoSmithKline's Rs 6,400-crore FDI proposal

The government on Thursday cleared Rs 6,400-crore (Rs 64-billion) FDI proposal of global healthcare company GlaxoSmithKline to acquire additional 24.33 per cent stake in its India arm. The Cabinet......

'GSK-Novartis deal not to impact India business'

GlaxoSmithKline Consumer Healthcare on Tuesday said the multi-billion dollar global deal between parent GlaxoSmithKline Plc and Swiss drug major Novartis won't affect its business in India. The two......

Novartis-Glaxo deal signals pharma firms don't have it easy

The multi-billion dollar three-way deal of Novartis with  GlaxoSmithKline (GSK) and Eli Lilly is likely to trigger merger control approvals from various anti-trust authorities, including a......